The Pulmonary Hypertension Association (PHA) has shared the results of its recent National Call-In Day, reporting that the event was…
Articles by PatrĂcia Silva, PhD
The Pulmonary Hypertension Association (PHA) has awarded 12 community activists with the 2015 Tom Lantos Innovation in Community…
The Pulmonary Hypertension Association (PHA) recently announced in a press release that it will take the lead in a global…
The Pulmonary Hypertension Association (PHA) has granted the PHA-accredited Center of Comprehensive Care (CCC) designation to the Pulmonary Hypertension Center…
Ascendis Pharma A/S, a clinical stage biotechnology company focused on creating drug candidates by improving existing drugs, recently announced results…
Findings from a recent study published in the Annals of Cardiac Anaesthesia determined that a multidisciplinary approach…
Researchers at the University of Glasgow and Glasgow Caledonian University in the United Kingdom published in the journal…
A new study led by researchers at Chengdu Women’s and Children’s Central Hospital in China revealed that angiotensin II interferes with…
Results from a recent study published in the journal Respirology showed that an early decline in 6-minute walk…
The Pulmonary Hypertension Association (PHA) is initiating a new social network, called myPHA, which was designed…
Recent work in preclinical models suggests that signaling via the pro-angiogenic and pro-inflammatory cytokine, CXCL12 (SDF-1), plays an…
Irving, Texas-based Reata Pharmaceuticals, Inc. has been granted orphan drug designation from the U.S.